Women’s Heart Health
The recording from the February 9th webinar is now available!
Create an optimal heart health plan for women of all ages!
Click here to read an article from Spokane Business Journal about a new home for the Heart Attack & Stroke Prevention Center
October 12, 2021 – Who should take a baby aspirin?
Much attention today in the public media about who should take a baby aspirin (81mg) for CV protection. The question is: Does the benefit outweigh the risk? Aspirin is a serious and dangerous medication and must be prescribed with great caution. The most significant risk with baby aspirin is bleeding. The main benefit of baby aspirin is to prevent a deadly clot from forming in the case of an inflammatory plaque rupture.
The US Preventative Services Task Force (USPSTF) published an update today to the recommendations of who should take baby aspirin for CV benefit. A Risk Model (FRS) is utilized to determine high or low risk. Unfortunately, many people with a low risk factor burden may have silent, deadly plaque. This ‘calculated risk score’ only looks at a few factors – age, gender, systolic BP, Good Cholesterol, and Smoking status.
Having atherosclerosis (plaque) is a prerequisite for having a CV event. How can it be determined who needs aspirin if the screening tool doesn’t assess for plaque?
The USPSTF is using the current definition of cardiovascular disease risk (CVD risk) which is a binary system – there are two categories:
- Primary Prevention: You have NOT had a CV event (Heart Attack or Ischemic Stroke). This is the category that is being disputed on who should take baby aspirin.
- Secondary Prevention: You HAVE had a CV event (Heart Attack or Ischemic Stroke) – Baby Aspirin (81mg) use in this category is not being disputed.
The question becomes…how many people in the traditional Primary Prevention category are walking around with silent plaque in the artery wall (subclinical atherosclerosis) and don’t know it?
The BaleDoneen Method has published a Ternary risk assessment model that uses the identification of plaque (atherosclerosis) to determine specific treatments:
If an individual was scanned and found to have plaque hiding in the artery wall, they are now classified as secondary prevention and aspirin therapy is necessary to prevent a CV event. Common tools for scanning to look for silent plaque include a Coronary Artery Calcium Scan (CACS) and a Carotid Intima Media Thickness Test (cIMT).
Primary Prevention – No plaque is present = NO BABY ASPIRIN. Goal: Prevent plaque development.
Secondary Prevention – Plaque is present (found with scanning) = YES ASPIRIN. Goal: Prevent CV Event.
Tertiary Prevention – Plaque has caused a CV event = YES ASPIRIN. Goal: Prevent a repeat CV Event.
Doneen, A., Bale, B, Leimgruber, P., Vigerust, D. (2020). “Cardiovascular Prevention: Migrating from a
binary to a ternary classification. Frontiers in CV Medicine.”
USPSTF Latest recommendations on baby aspirin
Alzheimers Prevention Jan 2021
Fact: Cardiovascular disease remains the leading cause of death and disability of both men and women in the U.S.
Fact: Every 20-30 seconds, someone in the U.S. has a heart attack or stroke.
Fact: Many heart attacks & strokes are repeat events.
Fact: Heart attacks and strokes can be prevented!
Fact: By being here, you’ve taken a vital step toward becoming actively engaged in your health.
Fact: First Video below explains optimal prevention!
From Amy Doneen, DNP. ARNP, HASPC Medical Director:
“So often when we mention our clinic we hear people respond by saying they’re glad they don’t need to come to us. Really, that’s thinking in reverse. The reality is that by coming to us first, we may well be able to help prevent a heart attack or stroke so that the need for a cardiologist doesn’t become a necessity.”
At the Heart Attack & Stroke Prevention Center (HASPC), we are 100% focused on heart attackprevention, stroke prevention, and providing optimal private care to individuals at risk. We practice the Bale Doneen Method using cutting edge techniques and technology to help predict and prevent the occurrence of heart attacks, ischemic strokes, and type 2 diabetes. While we do serve patients who have already experienced an event and are working to prevent another, our primary goal is to prevent heart attacks and strokes from occurring in the first place.
At The HASPC we believe you can avoid such tragedy and live your life to its fullest, and longest, potential. As internationally recognized leaders in the research and treatment of cardiovascular disease, we have years of experience confirming that heart attacks and strokes, as well as a closely related disease, Type 2 diabetes, can absolutely be prevented.
Taking your health to heart means doing all you can to make informed choices about the lifestyle factors you control and the genetic factors you inherit. As a patient at the Heart Attack & Stroke Prevention Center, you can expect us to provide the scientific foundation for those choices. And because our ultimate goal is your well-being and quality of life, you will receive attentive and highly individualized care to help you live the healthy life you desire.
Heart attack prevention. Stroke prevention. Quality of life. It’s what we’re committed to at The HASPC. Contact The Heart Attack & Stroke Prevention Center today — and take your wellness to heart.